153 related articles for article (PubMed ID: 17513310)
41. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
[TBL] [Abstract][Full Text] [Related]
42. Disposition of TF-PEG-Liposome-BSH in tumor-bearing mice.
Ito Y; Kimura Y; Shimahara T; Ariyoshi Y; Shimahara M; Miyatake S; Kawabata S; Kasaoka S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S109-10. PubMed ID: 19395268
[TBL] [Abstract][Full Text] [Related]
43. Enhancement of sodium borocaptate (BSH) uptake by tumor cells induced by glutathione depletion and its radiobiological effect.
Yoshida F; Matsumura A; Yamamoto T; Kumada H; Nakai K
Cancer Lett; 2004 Nov; 215(1):61-7. PubMed ID: 15374633
[TBL] [Abstract][Full Text] [Related]
44. Survival benefit of boron neutron capture therapy for recurrent malignant gliomas.
Miyatake S; Kawabata S; Yokoyama K; Kuroiwa T; Michiue H; Sakurai Y; Kumada H; Suzuki M; Maruhashi A; Kirihata M; Onoc K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S22-4. PubMed ID: 19394240
[TBL] [Abstract][Full Text] [Related]
45. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
[TBL] [Abstract][Full Text] [Related]
46. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
[TBL] [Abstract][Full Text] [Related]
47. BNCT of 3 cases of spontaneous head and neck cancer in feline patients.
Rao M; Trivillin VA; Heber EM; Cantarelli Mde L; Itoiz ME; Nigg DW; Rebagliati RJ; Batistoni D; Schwint AE
Appl Radiat Isot; 2004 Nov; 61(5):947-52. PubMed ID: 15308173
[TBL] [Abstract][Full Text] [Related]
48. Dosimetric evaluation of neutron capture therapy for local advanced breast cancer.
Yanagie H; Kumada H; Sakurai Y; Nakamura T; Furuya Y; Sugiyama H; Ono K; Takamoto S; Eriguchi M; Takahashi H
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S63-6. PubMed ID: 19427224
[TBL] [Abstract][Full Text] [Related]
49. Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy.
Miyajima Y; Nakamura H; Kuwata Y; Lee JD; Masunaga S; Ono K; Maruyama K
Bioconjug Chem; 2006; 17(5):1314-20. PubMed ID: 16984142
[TBL] [Abstract][Full Text] [Related]
50. A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment.
Alberti D; Protti N; Toppino A; Deagostino A; Lanzardo S; Bortolussi S; Altieri S; Voena C; Chiarle R; Geninatti Crich S; Aime S
Nanomedicine; 2015 Apr; 11(3):741-50. PubMed ID: 25596074
[TBL] [Abstract][Full Text] [Related]
51. Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model.
Fujimoto T; Andoh T; Sudo T; Fujita I; Moritake H; Sugimoto T; Sakuma T; Akisue T; Kawabata S; Kirihata M; Suzuki M; Sakurai Y; Ono K; Fukumori Y; Kurosaka M; Ichikawa H
Appl Radiat Isot; 2013 Mar; 73():96-100. PubMed ID: 23306161
[TBL] [Abstract][Full Text] [Related]
52. Improvement effect on the depth-dose distribution by CSF drainage and air infusion of a tumour-removed cavity in boron neutron capture therapy for malignant brain tumours.
Sakurai Y; Ono K; Miyatake S; Maruhashi A
Phys Med Biol; 2006 Mar; 51(5):1173-83. PubMed ID: 16481686
[TBL] [Abstract][Full Text] [Related]
53. First attempt of boron neutron capture therapy (BNCT) for hepatocellular carcinoma.
Suzuki M; Sakurai Y; Hagiwara S; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Kudo M; Ono K
Jpn J Clin Oncol; 2007 May; 37(5):376-81. PubMed ID: 17578894
[TBL] [Abstract][Full Text] [Related]
54. Bystander effect-induced mutagenicity in HPRT locus of CHO cells following BNCT neutron irradiation: characteristics of point mutations by sequence analysis.
Kinashi Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S325-7. PubMed ID: 19375934
[TBL] [Abstract][Full Text] [Related]
55. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Okabe M; Kirihata M; Ono K; Kuroiwa T
Radiat Res; 2007 Jan; 167(1):102-9. PubMed ID: 17214510
[TBL] [Abstract][Full Text] [Related]
56. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
[TBL] [Abstract][Full Text] [Related]
57. Combined use of sodium borocaptate and buthionine sulfoximine in boron neutron capture therapy enhanced tissue boron uptake and delayed tumor growth in a rat subcutaneous tumor model.
Yoshida F; Yamamoto T; Nakai K; Kumada H; Shibata Y; Tsuruta W; Endo K; Tsurubuchi T; Matsumura A
Cancer Lett; 2008 May; 263(2):253-8. PubMed ID: 18272285
[TBL] [Abstract][Full Text] [Related]
58. Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS.
Andoh T; Fujimoto T; Suzuki M; Sudo T; Sakurai Y; Tanaka H; Fujita I; Fukase N; Moritake H; Sugimoto T; Sakuma T; Sasai H; Kawamoto T; Kirihata M; Fukumori Y; Akisue T; Ono K; Ichikawa H
Appl Radiat Isot; 2015 Dec; 106():195-201. PubMed ID: 26337135
[TBL] [Abstract][Full Text] [Related]
59. Early clinical trial concept for boron neutron capture therapy: a critical assessment of the EORTC trial 11001.
Wittig A; Collette L; Moss R; Sauerwein WA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S59-62. PubMed ID: 19372041
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and in vitro evaluation of the phenylboric acid derivative entrapped lipiodol in boron neutron capture therapy for hepatoma.
Chou FI; Chung HP; Shieh MS; Huang CW; Chung RJ; Liu HM; Yang JY; Chi CW; Lin YC; Lui WY; Kai JJ
Anticancer Res; 2003; 23(5A):3955-63. PubMed ID: 14666703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
